Constructive Bio
PrivateLast Round
Series A
Extension
Mar 27, 2025
Total Funding Raised
$74.48M
Company Overview
Constructive Bio operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Series A Extension round in March 2025.
Constructive Bio is a biotechnology company that engineers synthetic genomes and cellular machinery to transform living cells into biofactories for the production of enzymes, pharmaceuticals, and biomaterials.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Constructive Bio Comparables
Compare Constructive Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ribbon Bio | 79% | |
| Camena Bioscience | 77% | |
| Pearl Bio | 74% |
For institutional investors. Book with your work email.
Constructive Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 27, 2025 | ||||
| Grant | Mar 5, 2025 | ||||
| Series A | Sep 24, 2024 | ||||
| Seed | Aug 15, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Constructive Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Amadeus Capital Partners | Seed |
| Fine Structure Ventures | Series A |
| OMX Ventures | Seed, Series A |
| F-Prime Capital | Series A |
| UKRI Innovate UK | Grant |
| +ND Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 42% MoM, reaching 4.6K.
- Oct 10, 2025
Partnered with the Ellison Institute of Technology and its Generative Biology Institute.
For institutional investors. Book with your work email.
Constructive Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Constructive Bio's valuation, stock price, and market status.
Is Constructive Bio a public or private company?
Constructive Bio is a private company.
What is the current stock price of Constructive Bio?
Constructive Bio is a private company, so its shares have no public market price. Caplight tracks Constructive Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Constructive Bio worth (valuation)?
Valuation information for Constructive Bio is not publicly available.
Can I buy Constructive Bio stock?
Constructive Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Constructive Bio's last funding round?
Constructive Bio's most recent funding round was Series A Extension on March 27, 2025.
Who are the main investors in Constructive Bio?
Key investors in Constructive Bio include OMX Ventures, Paladin Capital Group, Ahren Innovation Capital.
Will Constructive Bio IPO soon?
No public IPO plans have been announced for Constructive Bio.
How can I track Constructive Bio secondary market activity?
Caplight tracks bids, offers, and trades in Constructive Bio's shares on secondary markets.